Northern Health records highest rate of unregulated drug deaths in B.C. - CKPG Today
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
PRINCE GEORGE — Northern B. C. continues to be hit particularly hard by the toxic drug crisis, with new preliminary data showing Northern Health has the highest rate of unregulated drug deaths in the province this year. According to the BC Coroners Service, Northern Health has recorded a rate of 43 deaths per 100,000 people in 2026, ahead of Island Health at 34 per 100,000. The Northern Interior is also among the health service delivery areas with the highest death rates in B. C., while Nechako is among the local health areas recording the highest rates. Prince George has recorded 36 unregulated drug deaths so far in 2026. That compares with 67 in all of 2025 and 107 in 2024.
This article is an excerpt. To read the full content, visit the original source. CKPG Today
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!